Intracerebral Hematoma Occurring During Warfarin Versus Non–Vitamin K Antagonist Oral Anticoagulant Therapy
- 5 May 2016
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 118 (2), 222-225
- https://doi.org/10.1016/j.amjcard.2016.04.034
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationThe New England Journal of Medicine, 2011
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial FibrillationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2009
- The Role of Tissue Factor and Factor VIIa in HemostasisAnesthesia & Analgesia, 2009
- The impact of hyperacute blood pressure lowering on the early clinical outcome following intracerebral hemorrhageJournal of Hypertension, 2008
- Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial FibrillationJournal of the American College of Cardiology, 2007
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in AdultsStroke, 2007
- Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban—an Oral, Direct Factor Xa Inhibitor—Are Not Affected by AspirinThe Journal of Clinical Pharmacology, 2006
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988